Published • loading... • Updated
Glucotrack expands IP for glucose monitor sensor architectures
Summary by Drug Delivery Business
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Glucotrack expands IP for glucose monitor sensor architectures
Glucotrack 3-year continuous blood glucose monitor (CBGM) Glucotrack (Nasdaq:GCTK) announced today that it secured new intellectual property allowance protecting its continuous blood glucose monitor (CBGM). The patent application, titled “Methods and Systems for Continuously Monitoring the Glucose Level of a Patient,” was allowed by the U.S. Patent and Trademark Office (USPTO), expanding the IP protecting the CBGM as Glucotrack looks to advance …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
